Adjuvant therapy in the treatment of biliary tract cancer: A systematic review and meta-analysis

Journal of Clinical Oncology

Volumn 30, Issue 16, 2012, Pages 1934-1940

  Horgan, Anne M ^a,b   Amir, Eitan ^a   Walter, Thomas ^a   Knox, Jennifer J ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b WATERFORD REGIONAL HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; MITOMYCIN C; MITOXANTRONE;

ARTICLE; BILE DUCT TUMOR; BILIARY TRACT CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER SURVIVAL; ELECTRON BEAM TOMOGRAPHY; GALLBLADDER TUMOR; HUMAN; LYMPHADENECTOMY; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

BILE DUCT NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; GALLBLADDER NEOPLASMS; HUMANS; RADIOTHERAPY, ADJUVANT;

EID: 84863896346     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.40.5381     Document Type: Article

References (35)

1. Jemal A, Siegel R, Xu J, et al: Cancer statistics. CA Cancer J Clin 60:277-300, 2010
2. Anderson CD, Pinson CW, Berlin J, et al: Diagnosis and treatment of cholangiocarcinoma. Oncologist 9:43-57, 2004 (Pubitemid 38134013)
3. Howlader N, Noone AM, Krapcho M, et al: SEER cancer statistics review, 1975-2008, National Cancer Institute. http://seer.cancer.gov/csr/1975-2008
4. de Groen PC, Gores GJ, LaRusso NF, et al: Biliary tract cancers. N Engl J Med 341:1368-1378, 1999
5. Wade TP, Prasad CN, Virgo KS, et al: Experience with distal bile duct cancers in U.S. Veterans Affairs hospitals: 1987-1991. J Surg Oncol 64:242-245, 1997 (Pubitemid 27157415)
6. Jarnagin WR, Ruo L, Little SA, et al: Patterns of initial disease recurrence after resection of gall-bladder carcinoma and hilar cholangiocarcinoma: Implications for adjuvant therapeutic strategies. Cancer 98:1689-1700, 2003 (Pubitemid 37238626)
7. Hasegawa S, Ikai I, Fujii H, et al: Surgical resection of hilar cholangiocarcinoma: Analysis of survival and postoperative complications. World J Surg 31:1256-1263, 2007 (Pubitemid 47029903)
8. Valle J, Wasan H, Palmer DH, et al: Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362:1273-1281, 2010
9. Nakeeb A, Pitt HA: Radiation therapy, chemotherapy and chemoradiation in hilar cholangiocarcinoma. HPB (Oxford) 7:278-282, 2005 (Pubitemid 43878475)
10. Deeks JJ, Higgins JPT, Altman DG: Analysing and presenting results, in Higgins JPT, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions. Chichester, United Kingdom, John Wiley and Sons, 2006, pp 97-166
11. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 7:177-188, 1986 (Pubitemid 17189972)
12. Deeks JJ: Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 323:157-162, 2001
13. Takada T, Amano H, Yasuda H, et al: Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95:1685-1695, 2002
14. Vern-Gross TZ, Shivnani AT, Chen K, et al: Survival outcomes in resected extrahepatic cholangiocarcinoma: Effect of adjuvant radiotherapy in a Surveillance, Epidemiology, and End Results analysis. Int J Radiat Oncol Biol Phys 81:189-198, 2011
15. Wang SJ, Fuller CD, Kim JS, et al: Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol 26:2112-2117, 2008
16. Baton O, Azoulay D, Adam DV, et al: Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: Prognostic factors and longterm outcomes. J Am Coll Surg 204:250-260, 2007 (Pubitemid 46124042)
17. Gerhards MF, van Gulik TM, González González D, et al: Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg 27:173-179, 2003 (Pubitemid 36920167)
18. Gold DG, Miller RC, Haddock MG, et al: Adjuvant therapy for gallbladder carcinoma: The Mayo Clinic Experience. Int J Radiat Oncol Biol Phys 75:150-155, 2009
19. Heron DE, Stein DE, Eschelman DJ, et al: Cholangiocarcinoma: The impact of tumor location and treatment strategy on outcome. Am J Clin Oncol 26:422-428, 2003 (Pubitemid 36962091)
20. Hughes MA, Frassica DA, Yeo CJ, et al: Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys 68:178-182, 2007 (Pubitemid 46589827)
21. Itoh H, Nishijima K, Kurosaka Y, et al: Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder. Dig Dis Sci 50:2231-2242, 2005 (Pubitemid 43106373)
22. Lindell G, Holmin T, Ewers SB, et al: Extended operation with or without intraoperative (IORT) and external (EBRT) radiotherapy for gallbladder carcinoma. Hepatogastroenterology 50:310-314, 2003 (Pubitemid 36390507)
23. McMasters KM, Tuttle TM, Leach SD, et al: Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg 174:605-608, 1997; discussion 608-609
24. Morak MJ, van der Gaast A, Incrocci L, et al: Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: A prospective randomized controlled trial. Ann Surg 248:1031-1041, 2008
25. Murakami Y, Uemura K, Sudo T, et al: Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma. Ann Surg 250:950-956, 2009
26. Pitt HA, Nakeeb A, Abrams RA, et al: Perihilar cholangiocarcinoma: Postoperative radiotherapy does not improve survival. Ann Surg 221:788-797, 1995; discussion 797-798
27. Sagawa N, Kondo S, Morikawa T, et al: Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma. Surg Today 35:548-552, 2005 (Pubitemid 40854019)
28. Serafini FM, Sachs D, Bloomston M, et al: Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy. Am Surg 67:839-843, 2001; discussion 843-844
29. Todoroki T, Kawamoto T, Otsuka M, et al: Benefits of combining radiotherapy with aggressive resection for stage IV gallbladder cancer. Hepatogastroenterology 46:1585-1591, 1999 (Pubitemid 29366301)
30. Todoroki T, Ohara K, Kawamoto T, et al: Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys 46:581-587, 2000 (Pubitemid 30100635)
31. Zlotecki RA, Jung LA, Vauthey JN, et al: Carcinoma of the extrahepatic biliary tract: Surgery and radiotherapy for curative and palliative intent. Radiat Oncol Investig 6:240-247, 1998
32. Yeo CJ, Sohn TA, Cameron JL, et al: Periampullary adenocarcinoma: Analysis of 5-year survivors. Ann Surg 227:821-831, 1998 (Pubitemid 29119529)
33. Reference deleted
34. Neoptolemos JP, Stocken DD, Bassi C, et al: Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: A randomized controlled trial. JAMA 304:1073-1081, 2010
35. Pitt HA, Broelsch C, Fong Y, et al: Adjuvant therapy for biliary malignancies: International trends and possibilities. J Gastrointest Surg 7:309A, 2003